The Challenge
Preparing multi-country pharmaceutical submissions is a resource-intensive process. Even with experienced teams, the task of gathering data, formatting for different markets and regulatory regions, and ensuring consistency across hundreds of documents remains slow and labour-heavy.
Manual handling increases the risk of inconsistencies and errors, which can lead to re-work, missed deadlines, and delayed product launches. Even short delays can have a significant financial impact.
How T-Plan RPA Delivers
T-Plan’s Robotic Process Automation (RPA) platform streamlines the end-to-end submission process, enabling regulatory and operations teams to focus on decision-making rather than repetitive administration.
Core automation capabilities include:
- Data Collection: Automatically retrieves trial results, manufacturing records, and quality control logs from multiple systems and repositories.
- Smart Formatting: Converts and structures data to meet each regulator’s submission format requirements, ensuring consistent metadata across all documents.
- Automated Validation: Runs cross-checks against submission checklists, quickly flagging gaps or inconsistencies.
- Real-Time Tracking: Provides a single dashboard view of submission progress, deadlines, and feedback.
Business Value of RPA for Pharmaceutical Submissions
Adopting T-Plan RPA brings measurable improvements in speed, accuracy, and operational efficiency:
- Turnaround Speed: Reduce compilation timelines from 4–6 weeks to 5–7 days an 80% time saving.
- Error Reduction: Automated validation cuts submission errors by up to 70%, improving first-time acceptance rates.
- Operational Efficiency: Free up 30–40% of skilled regulatory staff capacity for higher-value tasks.
- Scalability: Manage multiple market submissions simultaneously without expanding headcount.
- Cost Savings: Shorter time-to-market can protect millions in potential daily revenue for high-value products.
- Audit Readiness: Complete, time-stamped records for every step, supporting Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) compliance.
Why it Matters
In competitive pharmaceutical markets, speed to approval directly affects both revenue potential and patient access. By replacing manual processes with automation, organisations can increase throughput, minimise risk, and ensure consistent quality across all submission packages.
T-Plan RPA is designed to integrate with existing systems, scale quickly, and deliver tangible ROI from the first deployment cycle. For teams under pressure to deliver faster without compromising compliance, automation provides a clear and proven path forward.
